Deletion of follicle-stimulating hormone (FSH) receptor residues encoded by exon one decreases FSH binding and signaling in the rat

Biology of Reproduction

Volumn 62, Issue 5, 2000, Pages 1240-1247

  Mann, Kathrin I ^a   Liu, Xunxian ^a   Dias, James A ^b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; FOLLITROPIN RECEPTOR;

ARTICLE; ENZYME ACTIVATION; EXON; FEMALE; FLOW CYTOMETRY; HORMONE RECEPTOR INTERACTION; IMMUNOBLOTTING; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

INSECTA;

EID: 0034008735     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod62.5.1240     Document Type: Article

References (48)

1. Simoni M, Gromoll J, Nieschlag E. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 1997; 18:739-773.
2. Robker RL, Richards JS. Hormonal control of the cell cycle in ovarian cells - proliferation versus differentiation. Biol Reprod 1998; 59:476-482.
3. Scott RT, Hodgen GD. The ovarian follicle: life cycle of a pelvic clock. Clin Obstet Gynecol 1990; 33:551-562.
4. Mosher WD, Pratt WF. Fecundity and infertility in the United States: incidence and trends. Fertil Steril 1991; 56:192-193.
5. Lapthorn AP, Harris DC, Littlejohn A. Crystal structure of human chorionic gonadotropin. Nature 1994; 369:455-461.
6. Wu H, Lusthader JW, Liu Y, Canfield RE, Hendrickson WA. Structure of human chorionic gonadotropin at 2.6 angstrom resolution from MAD analysis of the selenomethionyl protein. Structure 1994; 15: 545-558.
7. Dias JA, Lindau-Shepard B, Hauer C, Auger I. Human follicle-stimulating hormone structure-activity relationships. Biol Reprod 1998; 58: 1331-1336.
8. Sprengel R, Braun T, Nikolics K. The testicular receptor for follicle stimulating hormone: structure and functional expression of cloned cDNA. Mol Endocrinol 1990; 4:525-530.
9. Heckert LL, Daley IJ, Griswold MD. Structural organization of the follicle-stimulating hormone receptor gene. Mol Endocrinol 1992; 6: 70-80.
10. Sairam MR, Jiang LG, Yarney TA, Khan H. Follitropin signal transduction: alternative splicing of the FSH receptor gene produces a dominant negative form of receptor which inhibits hormone action. Biochem Biophys Res Commun 1996; 226:717-722.
11. Osuga Y, Kudo M, Kaipia A, Kobilka B. Hsueh AJ. Derivation of functional antagonists using N-terminal extracellular domain of gonadotropin and thyrotropin receptors. Mol Endocrinol 1997; 11:1659-1668.
12. Davis D, Liu X, Segaloff DL. Identification of the sites of N-linked glycosylation of the follicle-stimulating hormone (FSH) receptor and assessment of their role in FSH receptor function. Mol Endocrinol 1995; 9:159-170.
13. Ji I, Ji TH. Differential roles of exoloop 1 of the human follicle-stimulating hormone receptor in hormone binding and receptor activation. J Biol Chem 1995; 270:15970-15973.
14. Moyle WR, Campbell RK, Myers RV, Bernard MP, Han Y, Wang X. Co-evolution of ligand receptor pairs. Nature 1994; 368:251-255.
15. Reichert LE, Dattatreyamurty B. The follicle-stimulating hormone (FSH) receptor in testis: interaction with FSH. mechanism of signal transduction and properties of the purified receptor. Biol Reprod 1989; 40:13-26.
16. Dattatreyamurty B, Reichert LE Jr. Functional properties of polyclonal antibodies raised against the N-terminus region (residues 9-30) of the follicle-stimulating hormone (FSH) receptor: significance of this receptor region in FSH recognition and signal transduction. Endocrinology 1993; 133:1593-1601.
17. Leng N, Dattatreyamurty B, Reichert LE Jr. Identification of amino acid residues 300-315 of the rat FSH receptor as a hormone binding domain: evidence for its interaction with specific regions of FSH beta-subunit. Biochem Biophys Res Commun 1995; 210:392-399.
18. Quintana J, Hipken RW, Ascoli M. A polyclonal antibody to a synthetic peptidc derived from the rat follicle-stimulating hormone receptor reveals the recombinant receptor as a 74-kilodalton protein. Endocrinology 1993; 133:2098-2104.
19. Zijlstra-Westhoff WE, Slootstra JW, Puijk WC. In vitro inhibition of the bioactivity of follicle-stimulating hormone by antisera against a peptide representing part of the FSH-receptor. J Reprod Immunol 1998; 38:139-154.
20. Liu X. Depasquale JA, Griswold MD. Dias JA. Accessibility of rat and human follitropin receptor primary sequence (R265-S296) in situ. Endocrinology 1994; 135:682-691.
21. Gorman C. High efficiency gene transfer into mammalian cells. In: Glover DM (ed.), DNA Cloning: A Practical Approach Vol III. Washington: IRL Press; 1985: 143-190.
22. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
23. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350-4354.
24. Weiner RS, Andersen TT, Dias JA. Topographic analysis of the alpha-subunit of human follicle-stimulating hormone using site-specific antipeptide antisera. Endocrinology 1990; 127:573-579.
25. Roos P, Gemzell CA. The isolation of human pituitary follicle-stimulating hormone. Biochim Biophys Acta 1964; 82:218-220.
26. Greenwood FC, Hunter WM, Glover JS. The preparation of 131-I-labelled human growth hormone of high specific radioactivity. Biochem J 1963; 103:114-123.
27. Munson PJ, Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980; 107:220-2.39.
28. Hebert TE, Bouvier M. Structural and functional aspects of G protein-coupled receptor oligomerization. Biochem Cell Biol 1998; 76:1-11.
29. Bouvier M, Menard L, Dennis M, Marullo S. Expression and recovery of functional G-protein coupled receptors using baculovirus expression systems. Curr Opin Biotechnol 1998; 9:522-527.
30. Dattatreyamurty B, Reichert LE. Identification of regions of the follitropin(FSH) β-subunit that interact with the N-terminus regions (residues 9-30) of the FSH receptor. Mol Cell Endocrinol 1993; 93:39-46.
31. Dias JA, Zhang Y, Liu X. Receptor binding and functional properties of chimeric human follitropin prepared by an exchange between a small hydrophilic inter-cysteine loop of human follitropin and human lutropin. J Biol Chem 1994; 269:25289-25294.
32. Campbell RK, Dean-Emig DM, Moyle WR. Conversion of human choriogonadotropin into a follitropin by protein engineering. Proc Natl Acad Sci USA 1991; 88:760-764.
33. Grossmann M, Szkudlinski MW, Wong R. Substitution of the seatbelt region of the thyroid-stimulating hormone (TSH) beta-subunit with the corresponding regions of choriogonadotropin or follitropin confers luteotropic but not follitropic activity to chimeric TSH. J Biol Chem 1997; 272:15532-15540.
34. Braun T, Schofield PR, Sprengel R. Amino-terminal leucine-rich repeats in gonadotropin receptors determine hormone selectivity. EMBO J 1991; 10:1885-1890.
35. Khan H, Jiang LG, Jayashree GN, Yarney TA, Sairam MR. Recognition of follicle stimulating hormone (alpha-subunit) by a recombinant receptor protein domain coded by an alternately spliced mRNA and expressed in Escherichia coli. J Mol Endocrinol 1997; 19:183-190.
36. Sharma SC, Catterall JF. Expression of extracellular domain peptides of the FSH receptor and their effect on receptor-ligand interactions in vitro. Mol Cell Endocrinol 1995; 115:87-93.
37. Roche PC, Ryan RJ, McCormick DJ. Identification of hormone-binding regions of the luteinizing hormone/human chorionic gonadotropin receptor using synthetic peptides. Endocrinology 1992; 131:268-274.
38. Hong S, Phang T, Ji I, Ji TH. The amino-terminal region of the luteinizing hormone/choriogonadotropin receptor contacts both subunits of human choriogonadotropin. I. Mutational analysis. J Biol Chem 1998; 273:13835-13840.
39. Kosugi S, Ban T, Akamizu T, Kohn LD. Site-directed mutagenesis of a portion of the extracellular domain of the rat thyrotropin receptor important in autoimmune thyroid disease and nonhomologous with gonadotropin receptors. Relationship of functional and immunogenic domains. J Biol Chem 1991; 266:19413-19418.
40. Thomas D, Rozell TG, Liu X, Segaloff DL. Mutational analyses of the extracellular domain of the full-length lutropin/choriogonadotropin receptor suggest leucine-rich repeats 1-6 are involved in hormone binding. Mol Endocrinol 1996; 10:760-768.
41. Gromoll J, Simoni M, Nordhoff V, Behre HM, De Geyter C, Nieschlag E. Functional and clinical consequences of mutations in the FSH receptor. Mol Cell Endocrinol 1996; 125:177-182.
42. Rozzell TG, Wang H, Liu X, Segaloff DL. Intracellular retention of mutant gonadotropin receptors results in loss of hormone binding activity of the follitropin receptor but not of the lutropin/choriogonadotropin receptor. Mol Endocrinol 1995; 9:1727-1736.
43. Kobe B, Deisenhofer J. The leucine rich repeal: a versatile binding motif. TIBS 1994; 19:415-421.
44. Zhang R, Buczko E, Dufau ML. Requirement of cysteine residues in exons 1-6 of the extracellular domain of the luteinizing hormone receptor for gonadotropin binding. J Biol Chem 1996; 271:5755-5760.
45. Kobe B, Deisenhofer J. Crystal structure of porcine rihonuclease inhibitor, a protein with leucine-rich repeats. Nature 1993; 366:751-756.
46. Jiang X, Dreano M, Buckler DR. Structural predictions for the ligand-binding region of glycoprotein hormone receptors and the nature of hormone-receptor interactions. Structure 1995; 15:1341-1353.
47. Sairam MR, Jiang LG, Yarney TA, Khan H. Alternative splicing converts the G-protein coupled follitropin receptor gene into a growth factor type I receptor: implications for pleiotropic actions of the hormone. Mol Reprod Dev 1997; 48:471-479.
48. Yanagishita M, Rodbard D. Computer optimization of radioimmunoassays for hCG and estradiol: an experimental evaluation. Anal Biochem 1978; 88:1-19.